Bufalin enhances the killing efficacy of NK cells against hepatocellular carcinoma by inhibiting MICA shedding

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity

Lucas Ferrari de Andrade, Rong En Tay, Deng Pan et al. · Science · 2018 · 450 citations

Life Sciences, Immunology, Oncology +17

Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide

Delphine Maucort‐Boulch, Catherine de Martel, Silvia Franceschi et al. · International Journal of Cancer · 2018 · 366 citations · Full text

Medicine, Infectious Diseases, Oncology +15

Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial

Masatoshi Kudo, Sadahisa Ogasawara, Shuntaro Obi et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 309 citations · Full text

Medicine, Oncology, Pharmacology +15

Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall‐cell lung cancer, or pancreatic cancer

Zhiqiang Meng, Peiying Yang, Yehua Shen et al. · Cancer · 2009 · 285 citations · Full text

Medicine, Oncology, Pharmacology +15